Jeffrey V. Poulton

Insider Reports History

Entity
Individual
Location
300 Third Street, Cambridge, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Jeffrey V. Poulton
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jeffrey V. Poulton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer Common Stock 30.6K $7.73M $252.27 Nov 26, 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer Restricted Stock Units 3.82K $603K $158.09 Feb 27, 2024 Direct
Homology Medicines, Inc. Director Option (Right to Buy) 23K $309K $13.42 Jun 14, 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer Common Stock 57 $14.5K $254.48 Nov 25, 2024 by Managed Account
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Financial Officer Stock Option (right to buy) 15.1K Mar 1, 2024 Direct
CervoMed Inc. Director Stock Option (Right to Buy) 5.75K Jun 14, 2024 Direct

Insider Reports Filed by Jeffrey V. Poulton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALNY ALNYLAM PHARMACEUTICALS, INC. Nov 25, 2024 6 -$422K 4 Nov 27, 2024 EVP, Chief Financial Officer
ALNY ALNYLAM PHARMACEUTICALS, INC. Jun 24, 2024 13 -$371K 4 Jun 26, 2024 EVP, Chief Financial Officer
CRVO CervoMed Inc. Jun 14, 2024 1 $0 4 Jun 14, 2024 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Mar 1, 2024 2 $0 4 Mar 5, 2024 EVP, Chief Financial Officer
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 27, 2024 7 -$89.1K 4 Feb 29, 2024 EVP, Chief Financial Officer
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 15, 2024 4 -$149K 4 Feb 20, 2024 EVP, Chief Financial Officer
DFFN CervoMed Inc. Sep 15, 2023 1 $0 4 Sep 15, 2023 Director
DFFN CervoMed Inc. Aug 16, 2023 0 $0 3 Aug 23, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 3, 2023 8 -$643K 4 Aug 7, 2023 EVP, Chief Financial Officer
FIXX Homology Medicines, Inc. Jun 14, 2023 1 $0 4 Jun 15, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Apr 26, 2023 6 -$190K 4 Apr 28, 2023 EVP, Chief Financial Officer
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 27, 2023 2 $0 4 Mar 1, 2023 EVP, Chief Financial Officer
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 3, 2022 7 -$969K 4 Aug 5, 2022 EVP, Chief Financial Officer
FIXX Homology Medicines, Inc. Jun 15, 2022 1 $0 4 Jun 17, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Feb 23, 2022 1 $0 4 Feb 25, 2022 EVP, Chief Financial Officer
FIXX Homology Medicines, Inc. Jun 17, 2021 1 $0 4 Jun 22, 2021 Director